Higher MMP-9 serum levels have been related to Crohn’s disease relapses [113], while elevated plasma levels of MMP-2, -9 and -13 have been addressed as potential biomarkers of colorectal cancer [114–116]. The gene discussed is MMP9; the disease is Crohn disease.